Quant Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 24-07-2026
NAV ₹16.77(R) -0.47% ₹17.61(D) -0.47%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 7.62% 18.73% -% -% -%
Direct 9.36% 20.68% -% -% -%
Nifty Pharma TRI 14.21% 22.13% 12.63% 19.13% 8.72%
SIP (XIRR) Regular 19.17% 11.76% -% -% -%
Direct 21.07% 13.6% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 379 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 24-07-2026

Scheme Name NAV Rupee Change Percent Change
quant Healthcare Fund - IDCW Option - Regular Plan 16.76
-0.0800
-0.4700%
quant Healthcare Fund - Growth Option - Regular Plan 16.77
-0.0800
-0.4700%
quant Healthcare Fund - Growth Option - Direct Plan 17.61
-0.0800
-0.4700%
quant Healthcare Fund - IDCW Option - Direct Plan 17.61
-0.0800
-0.4700%

Review Date: 24-07-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 0.20 2.32
2.14
0.20 | 3.66 17 | 17 Poor
3M Return % 10.47 13.49
13.65
9.68 | 17.16 16 | 17 Poor
6M Return % 19.51 17.88
20.13
14.38 | 27.03 10 | 17 Good
1Y Return % 7.62 14.21
10.10
3.32 | 16.31 11 | 16 Average
3Y Return % 18.73 22.13
21.28
18.73 | 23.98 9 | 9 Average
1Y SIP Return % 19.17
22.29
3.60 | 32.36 11 | 16 Average
3Y SIP Return % 11.76
15.20
10.82 | 19.09 8 | 9 Average
Return data last Updated On : July 24, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 0.34 2.32 2.25 0.34 | 3.74 17 | 17 Poor
3M Return % 10.92 13.49 14.04 9.91 | 17.62 16 | 17 Poor
6M Return % 20.45 17.88 20.93 14.86 | 28.02 10 | 17 Good
1Y Return % 9.36 14.21 11.61 5.17 | 17.91 10 | 16 Average
3Y Return % 20.68 22.13 22.77 19.94 | 25.20 8 | 9 Average
1Y SIP Return % 21.07 24.09 5.05 | 34.42 10 | 15 Average
3Y SIP Return % 13.60 16.62 12.38 | 20.33 8 | 9 Average
Return data last Updated On : July 24, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Quant Healthcare Fund NAV Regular Growth Quant Healthcare Fund NAV Direct Growth
24-07-2026 16.7656 17.613
23-07-2026 16.8447 17.6953
22-07-2026 17.144 18.0089
21-07-2026 17.3184 18.1913
20-07-2026 17.2487 18.1173
17-07-2026 17.2661 18.1331
16-07-2026 17.4938 18.3714
15-07-2026 17.4311 18.3048
14-07-2026 17.2897 18.1554
13-07-2026 17.345 18.2127
10-07-2026 17.3124 18.1761
09-07-2026 17.1867 18.0433
08-07-2026 16.9286 17.7714
07-07-2026 17.2898 18.1498
06-07-2026 17.3642 18.2271
03-07-2026 17.3297 18.1885
02-07-2026 17.0957 17.9421
01-07-2026 16.9864 17.8266
30-06-2026 17.1112 17.9568
29-06-2026 16.841 17.6724
25-06-2026 16.7374 17.5606
24-06-2026 16.7315 17.5535

Fund Launch Date: 17/Jul/2023
Fund Category: Pharma Fund
Investment Objective: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Description: The primary investment objective of the scheme is to provide capital appreciation by investing in equity and equity related instruments including derivatives and debt and money market instruments. However, there can be no assurance that the investment objective of the Scheme will be realized, as actual market movements may be at variance with anticipated trends.
Fund Benchmark: BSE Healthcare TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.